suPAR biological age calculator

“It is essential to have the help of biomarkers, such as suPAR, which can support the discharge decision”

Juan González del Castillo, Dr PhD, Hospital Clínico San Carlos, Spain
suPAR News Vol. 1, April 2019

1: Xu X et al., Crystal structure of the urokinase receptor in a ligand-free form J Mol Biol. 2012 Mar 9;416(5):629-41.
2: Schneider UV et al., The prognostic value of the suPARnostic ELISA in HIV-1 infected individuals is not affected by uPAR promoterpolymorphisms, BMC Infect Dis. 2007 Nov 16;7:134
3. Huai Q, et al. Structure of human urokinase plasminogen activator in complex with its receptor, Science. 2006 Feb 3;311(5761):656-9.
4. Thunø M et al., suPAR: the molecular crystal ball, Dis Markers. 2009;27(3):157-72.

Want to know more about suPAR?

900+

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 4 products:

Quick Triage

A Point of Care Solution

TurbiLatex

For Automated Systems

ELISA Assay

Clinical and Research

suPARnostic POC+

POC+

Point-of-care finger prick

suPAR is used in clinical routine in 48 hospitals

48 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling.
This period covers January 1, 2022, until December 31, 2022. Some hospital locations cannot be disclosed due to confidentiality.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates